Defence Therapeutics Inc (DTC.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 1,941 | 1,530 | 1,685 | 691 | 442 |
| Operating Income | -1,941 | -1,530 | -1,685 | -691 | -442 |
| Pre-tax Income | -1,941 | -1,530 | -1,685 | -691 | -442 |
| Net Income Continuous | -1,941 | -1,530 | -1,685 | -691 | -442 |
| Net Income | $-1,941 | $-1,530 | $-1,685 | $-691 | $-442 |
| EPS Basic Total Ops | -0.05 | -0.04 | -0.05 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | -0.05 | -0.04 | -0.05 | N/A | N/A |
| EPS Diluted Total Ops | -0.05 | -0.04 | -0.05 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | -0.05 | -0.04 | -0.05 | N/A | N/A |
| EBITDA(a) | $-1,941 | $-1,530 | $-1,685 | $-691 | $-442 |